Zimmer Biomet Announces Fourth Quarter and Full-Year 2025 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/6/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 2c, Beats on Revenue; Offers FY26 EPS Guidance
February 10, 2026 6:32 AM ESTZimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.42, $0.02 better than the analyst estimate of $2.40. Revenue for the quarter came in at $2.24 billion versus the consensus estimate of $2.22 billion.
GUIDANCE:
Zimmer Biomet Holdings sees FY2026 EPS of $8.30-$8.45, versus the... More
